Pier picks Letendre as boss
This article was originally published in Scrip
Pier Pharmaceuticals, a sleep apnoea drug research company formerly known as Steady Sleep Rx, named Dr Peter Letendre as president and chief executive officer. Dr Letendre, who was previously president and founder of Greyhound Pharmaceutical Consulting LLC, will focus on raising new capital to develop the company's PP-001 compound, which is being developed to treat obstructive sleep apnoea. Pier's existing investors include Illinois Ventures and Origin Ventures.